Does levodopa therapy delay death in Parkinson's disease?

Mov Disord. 1996 May;11(3):343-4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use*
  • Humans
  • Levodopa / adverse effects
  • Levodopa / therapeutic use*
  • Minnesota / epidemiology
  • Parkinson Disease / drug therapy
  • Parkinson Disease / mortality*
  • Survival Analysis

Substances

  • Antiparkinson Agents
  • Levodopa